COMMUNIQUÉS West-GlobeNewswire

HTG Molecular Diagnostics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

23/01/2018 - 22:01

TUCSON, Ariz., Jan. 23, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM ) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced the [...]

Five Prime Announces Proposed Public Offering of Common Stock

23/01/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq: FPRX ), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology [...]

Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer

23/01/2018 - 20:15

DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of [...]

Trident Brands Appoints Senior Industry Executive Bob Dufour To Advisory Board

23/01/2018 - 19:50

BROOKFIELD, WI, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Trident Brands, Inc. (OTCQB: TDNT), a consumer products company focused on novel and unique branded products, private label manufacturing and proprietary innovation [...]

United American Healthcare Corporation Reports Strong Income Growth in Q3 Fiscal Year 2017 Propelled by Performance of its Wholly Owned Subsidiaries

23/01/2018 - 19:45

CHICAGO, Jan. 23, 2018 (GLOBE NEWSWIRE) -- United American Healthcare Corporation (OTC:UAHC) (the “Company” or “UAHC Parent”), today announced the release of its unaudited third quarter report ending September 30, 2017 [...]

Barbara Ann Karmanos Cancer Institute receives 2018 Women’s Choice Award® as one of America’s Best Hospitals for Cancer Care & Research

23/01/2018 - 19:42

DETROIT, Jan. 23, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute has been named one of America’s Best Hospitals for Cancer Care & Research by the Women’s Choice Award ® for 2018. Previously, [...]

Nohla Therapeutics Granted Orphan Drug Designation in the European Union for NLA101 in the Treatment of Hematopoietic Stem Cell Transplantation

23/01/2018 - 19:00

SEATTLE, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a clinical stage biopharmaceutical company focused on the development of universal donor, off-the-shelf cell therapies to treat cancer and [...]

Premier Biomedical Launches Hemp Oil Based Topical Pain Relief Ointment

23/01/2018 - 16:25

JACKSON CENTER, Pa., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) announced introduction of a new hemp oil based topical ointment to complement its existing topical pain relief products, which [...]

Cynata Executes MoU for Commercial Evaluation with Celularity, Inc.

23/01/2018 - 16:05

MoU signed with Celularity, Inc. for the evaluation of and identification of commercial opportunities for the Cymerus TM platform and Celularity’s leading cell therapy assets Follows encouraging early clinical data in [...]

Shire Continues to Uphold High Standards of Ethics and Transparency with Adoption of Open Access Policy for Publication of Shire-Supported Research

23/01/2018 - 16:00

Shire Continues to Uphold High Standards of Ethics and Transparency with Adoption of Open Access Policy for Publication of Shire-Supported Research Cambridge, MA - January 23, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG), [...]

HIFU for Prostate Cancer Now Available at Chesapeake Urology

23/01/2018 - 16:00

CHARLOTTE, N.C., Jan. 23, 2018 (GLOBE NEWSWIRE) -- HIFU Prostate Services, LLC, the leading provider of HIFU technology to physician practices in the United States, is excited to announce a partnership with Chesapeake [...]

AFA: Signing of New RAISE Family Caregiver Law Positive Step, But Continued Action Needed from Washington

23/01/2018 - 15:50

NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) heralded the signing of the new RAISE Family Caregiver Act, which will provide a desperately needed comprehensive national plan for [...]

K2M Group Holdings, Inc. to Release Fourth Quarter and Fiscal Year 2017 Financial Results on February 28th

23/01/2018 - 15:30

LEESBURG, Va., Jan. 23, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

Cocrystal Pharma Announces 1-for-30 Reverse Stock Split

23/01/2018 - 15:15

– Reverse stock split positions Company to uplist to the NASDAQ Capital Market in Q1 2018 – – Company expects to commence Phase 2a study in Q1 2018 for lead program, CC-31244, for the treatment of hepatitis C infection [...]

Obalon Announces Termination of Public Offering of Common Stock

23/01/2018 - 15:13

SAN DIEGO, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (the “Company” or “Obalon”) (NASDAQ: OBLN ) today announced the termination of the underwriting agreement and cancellation of its previously [...]

AXIM Biotech Announces Successful Completion of Exploratory Meeting with the Dutch Medicines Evaluation Board on MedChew Rx Program for Treatment of Pain and Spasticity in MS Patients

23/01/2018 - 15:00

NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM), the world leader in cannabinoid research and development, announced today that it has successfully completed an exploratory meeting [...]

Data on Novel Humanized Models for Targeted Immunotherapy Development, a CrownBio Conference Talk on January 24th, 2018

23/01/2018 - 14:40

SAN DIEGO, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

Solon Eiendom ASA : Primary insider notification

23/01/2018 - 14:35

(Oslo, Norway, 23 January 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 21,481 shares in Solon Eiendom ASA at a price of NOK 21.404 per share [...]

Cannabix Technologies Provides Update on Marijuana Breathalyzer Development

23/01/2018 - 14:30

VANCOUVER, British Columbia, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and [...]